Furthermore, genome-wide association studies (GWAS) and targeted analyses demonstrated that common genetic variants of TRAF3, which reduce TRAF3 expression, are associated with an increased risk of B cell malignancies, systemic lupus erythematosus, hypergammaglobulinemia, and recurrent bacterial infection in a wider population (14). The gene discussed is TRAF3; the disease is bacterial infectious disease.